Literature DB >> 20699760

Intermediate-term follow-up of patients treated with percutaneous embolization for grade 5 blunt renal trauma.

Adam F Stewart1, M Eric Brewer, Brian J Daley, Frederick A Klein, Edward D Kim.   

Abstract

BACKGROUND: The short-term efficacy and safety of percutaneous embolization for the treatment of hemodynamically unstable patients with grade 5 renal injuries secondary to blunt trauma has been previously established; however, there has been no published intermediate-term follow-up. The purpose of this study is to report intermediate-term follow-up and complications for this treatment modality.
METHODS: A retrospective study was performed to determine intermediate-term outcomes in an observational cohort of patients who underwent percutaneous embolization for the management of grade 5 blunt renal trauma. Demographic and perioperative data were obtained. Follow-up was performed via mail and/or phone questionnaires.
RESULTS: Between October 2004 and July 2008, 10 hemodynamically unstable patients with grade 5 blunt renal trauma were treated with percutaneous embolization. Mean age of the cohort was 29 years (range, 5-50). Mean follow-up via phone and/or mail questionnaires was 2.7 years (1.5-5.1 years). One patient reported a new diagnosis of hypertension, which is well controlled by a single antihypertensive medication. There were no reported complications of refractory hypertension, altered renal function, new urolithiasis, chronic pain, urine leak, arteriovenous fistula, or pseudoaneurysm. No other procedures were required after the initial embolization for their renal trauma.
CONCLUSIONS: Management of grade 5 renal injuries with percutaneous embolization is safe and is not associated with intermediate-term adverse events.

Entities:  

Mesh:

Year:  2010        PMID: 20699760     DOI: 10.1097/TA.0b013e3181e5407a

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  8 in total

1.  Selective angioembolization for traumatic renal injuries: a survey on clinician practice.

Authors:  Allison S Glass; Ayesha A Appa; Stacey A Kenfield; Herman S Bagga; Sarah D Blaschko; James B McGeady; Jack W McAninch; Benjamin N Breyer
Journal:  World J Urol       Date:  2013-09-27       Impact factor: 4.226

2.  [Operative interventions of urologic traumata in severe injured patients in the acute phase].

Authors:  A Hegele; R Lefering; J Hack; S Ruchholtz; R Hofmann; C A Kühne
Journal:  Urologe A       Date:  2016-04       Impact factor: 0.639

Review 3.  "Beyond saving lives": Current perspectives of interventional radiology in trauma.

Authors:  Anuradha Singh; Atin Kumar; Pawan Kumar; Subodh Kumar; Shivanand Gamanagatti
Journal:  World J Radiol       Date:  2017-04-28

4.  Traumatic renal vein pseudoaneurysm.

Authors:  Eric J Monroe; Matthew J Kogut; Christopher R Ingraham
Journal:  J Vasc Surg Cases       Date:  2015-06-18

5.  The epidemiology of renal trauma.

Authors:  Bryan B Voelzke; Laura Leddy
Journal:  Transl Androl Urol       Date:  2014-06

Review 6.  Kidney and uro-trauma: WSES-AAST guidelines.

Authors:  Federico Coccolini; Ernest E Moore; Yoram Kluger; Walter Biffl; Ari Leppaniemi; Yosuke Matsumura; Fernando Kim; Andrew B Peitzman; Gustavo P Fraga; Massimo Sartelli; Luca Ansaloni; Goran Augustin; Andrew Kirkpatrick; Fikri Abu-Zidan; Imitiaz Wani; Dieter Weber; Emmanouil Pikoulis; Martha Larrea; Catherine Arvieux; Vassil Manchev; Viktor Reva; Raul Coimbra; Vladimir Khokha; Alain Chichom Mefire; Carlos Ordonez; Massimo Chiarugi; Fernando Machado; Boris Sakakushev; Junichi Matsumoto; Ron Maier; Isidoro di Carlo; Fausto Catena
Journal:  World J Emerg Surg       Date:  2019-12-02       Impact factor: 5.469

Review 7.  Endovascular Interventional Radiology of the Urogenital Tract.

Authors:  Fabio Pozzi Mucelli; Roberta A Pozzi Mucelli; Cristina Marrocchio; Saverio Tollot; Maria A Cova
Journal:  Medicina (Kaunas)       Date:  2021-03-17       Impact factor: 2.430

8.  The role of angioembolization in the management of blunt renal injuries: a systematic review.

Authors:  Giovanni Liguori; Giacomo Rebez; Alessandro Larcher; Michele Rizzo; Tommaso Cai; Carlo Trombetta; Andrea Salonia
Journal:  BMC Urol       Date:  2021-08-06       Impact factor: 2.264

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.